Author

C. Damoci

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A. Basseville· 1 shared D. Romo· 1 shared D. V. Morales· 1 shared H. Xue· 1 shared K. Hull· 1 shared K. P. Olive· 1 shared L. Petrukhin· 1 shared L. Scotto· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Basseville

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma

M. Safari, L. Scotto, A. Basseville, T. Litman, H. Xue, L. Petrukhin, P. Zhou, D. V. Morales, C. Damoci, M. Zhu, K. Hull, K. P. Olive, T. Fojo, D. Romo, S. E. Bates

This paper shows that combining HDAC and eIF4A inhibitors effectively treats pancreatic cancer by inducing epigenetic reprogramming and metabolic stress in preclinical models.

bioRxiv · Jun 30, 2024Cancer Biology